The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Dainippon Pharmaceutical Co., Ltd.

Dainippon Pharmaceutical Co., Ltd.
 PROFILE
Get high with Dai! Dainippon Pharmaceutical is one of five firms in Japan licensed to manufacture and sell narcotics for medical use; the company's products include ANPEC and KADIAN, morphine preparations for cancer pain treatment. Dainippon also produces allergy treatments, cardiovascular disorder drugs, and antifungal chemotherapeutics. The company is selling its epileptic seizure drug ZONEGRAN on the US market with Irish pharmaceutical giant Elan. In addition, Dainippon makes food and feed additives, veterinary drugs, and diagnostic products.

 COMPETITION
Sankyo Co., Ltd. (4501)
Takeda Chemical Industries, Ltd. (4502)
Yamanouchi Pharmaceutical Co., Ltd. (dossier)

 FINANCIAL OVERVIEW
Fiscal Year-End: March
2000 Sales (mil.): 1,473.80
1-Yr. Sales Growth: 19.9%
Employees: 2,521
Revenue per employee: $584,609.28

 KEY PEOPLE
• Kenjiro Miyatake
    CEO
• Toshihauru Akai
    CFO

 CONTACT INFO
6-8 Doshomachi 2-chome, Chuo-ku
Osaka 541-0045, Japan
Phone: 81-662-5307
Fax: 81-662-6581
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001